Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

530 trials

NCT06796543
Recruiting
Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma
Not applicable · United States · 3 sites
Registry update: 13 Jul 2026
NCT06889766
Recruiting
NY-ESO-1-redirected T Cells in Patients With Advanced Melanoma and Sarcoma
Phase 1 · Switzerland · 2 sites
Registry update: 15 May 2026
NCT06721689
Recruiting
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Phase 1/2 · United States · 7 sites
Registry update: 6 Oct 2026
NCT06025747
Recruiting
A Phase 1 Study of Neoadjuvant Abemaciclib in Combination With Radiation Therapy for Liposarcomas
Phase 1 · United States · 1 site
Registry update: 17 Sept 2026
NCT07793006
Recruiting
New Approaches for the Diagnosis of Lymphoma and Multicentric Castleman Disease
Not applicable · Malawi · 1 site
Registry update: 28 Aug 2026
NCT06052618
Recruiting
Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS)
Phase 2 · United States · 1 site
Registry update: 16 Oct 2026
NCT07888114
Recruiting
Preliminary Clinical Study of Entinostat in Children With Malignant Soft Tissue Sarcoma Harboring PAX-family Gene Abnormalities
Phase 1 · China · 1 site
Registry update: 22 Oct 2026
NCT06924463
Recruiting
Identification of Specific Molecular Signatures in Pediatric, Adolescent, and Young Adult Rhabdomyosarcoma Through Spatial Proteome Analysis Using Mass Spectrometry
Not applicable · France · 1 site
Registry update: 11 Apr 2025
NCT06873685
Recruiting
Soft Tissue Sarcoma: Motor Performance, Robotic Rehabilitation, Nutrition, and Quality of Life
Not applicable · Italy · 3 sites
Registry update: 21 Mar 2025
NCT06578624
Recruiting
Safety and Preliminary Efficacy of SA53-OS in Patients With Locally Advanced or Metastatic Solid Tumors
Phase 1/2 · United States · 3 sites
Registry update: 9 Sept 2026
NCT06774729
Recruiting
Development of a Radiomics Model With MR to Predict the Occurence of a Infiltration of Muscoskeletal Tumor
Not applicable · Italy · 1 site
Registry update: 14 Jan 2025
NCT04199026
Recruiting
Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma
Not applicable · United States · 1 site
Registry update: 11 Aug 2026
NCT06849986
Recruiting
IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS)
Phase 2 · China · 1 site
Registry update: 8 Jan 2026
NCT06751355
Recruiting
Precision Imaging to Evaluate Kaposi Sarcoma (PRIME-KS): A Device Feasibility Trial
Not applicable · United States · 1 site
Registry update: 25 Mar 2026
NCT06843967
Recruiting
A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma
Phase 1/2 · United States · 7 sites
Registry update: 16 Sept 2026
NCT06760819
Recruiting
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Phase 2 · Australia, Canada, Switzerland, China, Denmark, Spain, France, Italy, Japan, South Korea, United States · 54 sites
Registry update: 4 Nov 2026
NCT07141862
Recruiting
Fertility Preservation in Children With Solid Tumors: Detection of Residual Disease by a Sensitive Method
Not applicable · France · 1 site
Registry update: 3 Sept 2025
NCT06816771
Recruiting
Evaluation of the Efficacy and Safety of Pazopanib in Combination with TGI/CIV for Recurrent or Refractory Rhabdomyosarcoma in Children or Adolescents
Phase 2 · China · 1 site
Registry update: 10 Feb 2025
NCT06815666
Recruiting
BAL Fluid Biomarkers in Sarcoma
Phase 2 · Canada · 1 site
Registry update: 4 Mar 2026
NCT06709495
Recruiting
Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
Phase 1/2 · United States · 3 sites
Registry update: 19 Feb 2026

Ordered by registry start date. Freshness and sponsorship never change the order.